[EN] TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TRICYCLIQUES ET INHIBITEURS DE JAK
申请人:NISSAN CHEMICAL IND LTD
公开号:WO2013024895A1
公开(公告)日:2013-02-21
Novel tricyclic pyrimidine compounds and tricyclic pyridine compounds having JAK inhibitory activities are provided. A tricyclic heterocyclic compound represented by the formula (Ia): wherein the rings Aa and Ba, Xa, Ya, R1a, R2a, R3a, L1a, L2a, L3a and na are as defined in the description.
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS
申请人:Hayashi Keishi
公开号:US20140200344A1
公开(公告)日:2014-07-17
Novel tricyclic pyrimidine compounds and tricyclic pyridine compounds having JAK inhibitory activities are provided. A tricyclic heterocyclic compound represented by the formula (I
a
): wherein the rings A
a
and B
a
, X
a
, Y
a
, R
1a
, R
2a
, R
3a
, L
1a
L
2a
, L
3a
and n
a
are as defined in the description.